Rafferty Asset Management
IGMS

Rafferty Asset Management’s IGM Biosciences IGMS Stock Holding History

Rafferty Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,057
Closed -$1.64M – 1269
2021
Q4 		$1.64M Buy
56,057
+27,100
+94% +$1.35M 0.01% 729
2021
Q3 		$1.9M Buy
28,957
+3,262
+13% +$250K 0.01% 652
2021
Q2 		$2.14M Sell
25,695
-12,242
-32% -$907K 0.01% 670
2021
Q1 		$2.91M Buy
37,937
+31,672
+506% +$2.88M 0.02% 514
2020
Q4 		$553K Sell
6,265
-2,186
-26% -$154K 0.01% 660
2020
Q3 		$624K Buy
8,451
+5,198
+160% +$308K 0.01% 658
2020
Q2 		$237K Buy
+3,253
New +$198K ﹤0.01% 881

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Rafferty Asset Management's IGMS Position: Q1 2022 in Review

Rafferty Asset Management sold out of IGM Biosciences (IGMS) in Q1 2022, closing a stake of 56,057 shares — an estimated $1.64M sold.

Rafferty Asset Management first reported a position in IGMS in Q2 2020 and held it in 7 quarters. The position peaked at $2.91M in Q1 2021. 93 funds tracked by Wall St. Rank hold IGMS as of Q1 2022.

  • Rafferty Asset Management reported no remaining IGM Biosciences position as of Q1 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 56,057 IGM Biosciences shares in Q1 2022, an estimated $1.64M.
  • Rafferty Asset Management first reported a position in IGM Biosciences in Q2 2020 and held it in 7 quarters.
  • Rafferty Asset Management's IGM Biosciences position peaked at $2.91M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2022.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.